<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo2398" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38895560</article-id><article-id pub-id-type="pmc">PMC11182783</article-id>
<article-id pub-id-type="doi">10.1002/deo2.398</article-id><article-id pub-id-type="publisher-id">DEO2398</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Iron deposition in gastric black spots: Clinicopathological insights and NanoSuit&#x02010;correlative light and electron microscopy analysis</article-title><alt-title alt-title-type="left-running-head">SUGIURA <sc>et al</sc>.</alt-title></title-group><contrib-group><contrib id="deo2398-cr-0001" contrib-type="author"><name><surname>Sugiura</surname><given-names>Kiichi</given-names></name><xref rid="deo2398-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2398-cr-0002" contrib-type="author"><name><surname>Kawasaki</surname><given-names>Hideya</given-names></name><xref rid="deo2398-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2398-cr-0003" contrib-type="author"><name><surname>Egami</surname><given-names>Takatoshi</given-names></name><xref rid="deo2398-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2398-cr-0004" contrib-type="author"><name><surname>Kaneko</surname><given-names>Masanao</given-names></name><xref rid="deo2398-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2398-cr-0005" contrib-type="author"><name><surname>Ishida</surname><given-names>Natsuki</given-names></name><xref rid="deo2398-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2398-cr-0006" contrib-type="author"><name><surname>Tamura</surname><given-names>Satoshi</given-names></name><xref rid="deo2398-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2398-cr-0007" contrib-type="author"><name><surname>Tani</surname><given-names>Shinya</given-names></name><xref rid="deo2398-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2398-cr-0008" contrib-type="author"><name><surname>Yamade</surname><given-names>Mihoko</given-names></name><xref rid="deo2398-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2398-cr-0009" contrib-type="author"><name><surname>Hamaya</surname><given-names>Yasushi</given-names></name><xref rid="deo2398-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2398-cr-0010" contrib-type="author"><name><surname>Osawa</surname><given-names>Satoshi</given-names></name><xref rid="deo2398-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="deo2398-cr-0011" contrib-type="author"><name><surname>Takeuchi</surname><given-names>Hiroya</given-names></name><xref rid="deo2398-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="deo2398-cr-0012" contrib-type="author"><name><surname>Baba</surname><given-names>Satoshi</given-names></name><xref rid="deo2398-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="deo2398-cr-0013" contrib-type="author"><name><surname>Sugimoto</surname><given-names>Ken</given-names></name><xref rid="deo2398-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2398-cr-0014" contrib-type="author" corresp="yes"><name><surname>Iwaizumi</surname><given-names>Moriya</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2629-0830</contrib-id><xref rid="deo2398-aff-0006" ref-type="aff">
<sup>6</sup>
</xref><address><email>iwaizumi@hama-med.ac.jp</email></address></contrib></contrib-group><aff id="deo2398-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">First Department of Medicine</named-content>
<institution>Hamamatsu University School of Medicine</institution>
<city>Shizuoka</city>
<country country="JP">Japan</country>
</aff><aff id="deo2398-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Institute for NanoSuit Research</named-content>
<named-content content-type="organisation-division">Preeminent Medical Photonics Education and Research Center</named-content>
<institution>Hamamatsu University School of Medicine</institution>
<city>Shizuoka</city>
<country country="JP">Japan</country>
</aff><aff id="deo2398-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Endoscopic and Photodynamic Medicine</named-content>
<institution>Hamamatsu University School of Medicine</institution>
<city>Shizuoka</city>
<country country="JP">Japan</country>
</aff><aff id="deo2398-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Surgery</named-content>
<institution>Hamamatsu University School of Medicine</institution>
<city>Shizuoka</city>
<country country="JP">Japan</country>
</aff><aff id="deo2398-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Diagnostic Pathology</named-content>
<institution>Hamamatsu University School of Medicine</institution>
<city>Shizuoka</city>
<country country="JP">Japan</country>
</aff><aff id="deo2398-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Department of Laboratory Medicine</named-content>
<institution>Hamamatsu University School of Medicine</institution>
<city>Shizuoka</city>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Moriya Iwaizumi, Department of Laboratory Medicine, Hamamatsu University School of Medicine, 1&#x02010;20&#x02010;1 Handayama, Chuo&#x02010;ku, Hamamatsu, Shizuoka 431&#x02013;3192, Japan.<break/> Email: <email>iwaizumi@hama-med.ac.jp</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>6</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="118">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e398</elocation-id><history>
<date date-type="rev-recd"><day>23</day><month>5</month><year>2024</year></date>
<date date-type="received"><day>10</day><month>3</month><year>2024</year></date>
<date date-type="accepted"><day>03</day><month>6</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e398.pdf"/><abstract><title>Abstract</title><sec id="deo2398-sec-0010"><title>Objectives</title><p>Black spots (BSs) are lentiginous findings observed in the gastric body and fundus during upper gastrointestinal endoscopy and are predominantly seen in patients undergoing <italic toggle="yes">Helicobacter pylori</italic> eradication treatment. However, the detailed patient background and exact composition are poorly understood. This study aims to clarify the clinicopathological features of BSs, examine patient demographics, and use the NanoSuit&#x02010;correlative light and electron microscopy (CLEM) method combined with scanning electron microscopy&#x02010;energy dispersive X&#x02010;ray spectroscopy for elemental analysis.</p></sec><sec id="deo2398-sec-0020"><title>Methods</title><p>Patients who underwent upper gastrointestinal endoscopy between 2017 and 2022 were included. Data on age, medications, blood tests, and <italic toggle="yes">H. pylori</italic> infection status were retrospectively gathered from medical records. Univariate analysis was conducted to examine BS presence, with results then used in a multivariate model to identify associated risk factors. Additionally, pathological specimens from patients with BSs were analyzed for elemental composition using the NanoSuit&#x02010;CLEM method combined with scanning electronmicroscopy&#x02010;energy dispersive X&#x02010;ray spectroscopy.</p></sec><sec id="deo2398-sec-0030"><title>Results</title><p>An analysis of 6778 cases identified risk factors for BSs, including older age and using proton pump inhibitors, statins, corticosteroids, and antithrombotic drugs. Endoscopically, BSs correlated with higher gastric atrophy and lower active <italic toggle="yes">H. pylori</italic> infection. Iron deposition at BS sites was specifically identified using NanoSuit&#x02010;CLEM.</p></sec><sec id="deo2398-sec-0040"><title>Conclusions</title><p>BSs on gastrointestinal endoscopy may indicate an absence of active <italic toggle="yes">H. pylori</italic> inflammation. The discovery of iron deposition within BSs using the NanoSuit&#x02010;CLEM method has offered new insights into the possible causative factors and advances our understanding of the etiology of BSs, bringing us closer to unraveling the underlying mechanisms of their formation.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo2398-kwd-0001">deposition</kwd><kwd id="deo2398-kwd-0002">gastric</kwd><kwd id="deo2398-kwd-0003">gastrointestinal endoscopy</kwd><kwd id="deo2398-kwd-0004"><italic toggle="yes">Helicobacter pylori</italic></kwd><kwd id="deo2398-kwd-0005">iron</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Japan Society for the Promotion of Science
</institution><institution-id institution-id-type="doi">10.13039/501100001691</institution-id></institution-wrap></funding-source><award-id>22K08053</award-id></award-group></funding-group><counts><fig-count count="5"/><table-count count="3"/><page-count count="11"/><word-count count="5252"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="deo2398-sec-0050"><title>INTRODUCTION</title><p>Black spots (BSs) manifest as lentiginous anomalies identifiable in the gastric body and fundus during gastroscopic examination.<xref rid="deo2398-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Histological examination via light microscopy reveals the presence of brownish deposits within the lumina of fundic gland cysts. Notably, BSs are detected in 6.2% of individuals subjected to gastroscopy, with a pronounced prevalence among those receiving <italic toggle="yes">Helicobacter pylori</italic> eradication therapy or proton pump inhibitor (PPI) medication.<xref rid="deo2398-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo2398-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> Moreover, BSs are commonly identified adjacent to gastric adenocarcinomas of the fundic gland type, thereby providing a significant adjunct in the diagnostic process of these specific gastric neoplasms.<xref rid="deo2398-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="deo2398-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="deo2398-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>
</p><p>Despite the scrutiny of BSs through immunohistochemical staining and polarized light microscopy, their molecular composition and structure remain unknown.<xref rid="deo2398-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Various methodologies, including mass spectrometry, proteomic profiling, and electron spin resonance, have characterized deposits in pathological samples. However, the definitive identification of these compounds frequently proves challenging. Against this background, we have developed certain substances that polymerize when exposed to electron or plasma irradiation on the epidermis of specific insects, forming a nanometer&#x02010;thick protective layer known as the &#x0201c;NanoSuit.&#x0201d; This innovation has demonstrated the feasibility of preserving diminutive organisms during scanning electron microscopy (SEM) analysis.<xref rid="deo2398-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> We have harnessed this technique to pioneer a novel investigative approach called the NanoSuit&#x02010;correlative light and electron microscopy (NanoSuit&#x02010;CLEM) and have further integrated energy dispersive X&#x02010;ray spectroscopy (EDS) analysis into this approach.<xref rid="deo2398-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="deo2398-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Utilizing this technique, we have successfully identified lanthanum phosphate deposits within gastric tissue.<xref rid="deo2398-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> Nevertheless, there are no studies in the literature that have used this innovative technique for the analysis of BSs.</p><p>This study's primary objective is to understand the clinicopathological characteristics of BSs comprehensively. This involves a detailed analysis of patient backgrounds, including the status of <italic toggle="yes">H. pylori</italic> infection and detailed pharmacological histories. Additionally, the study aims to employ the NanoSuit&#x02010;CLEM method combined with SEM&#x02010;EDS for elemental analysis. This approach is expected to provide a deeper insight into the composition and potential causative factors of BSs, thereby contributing significantly to the understanding of these clinical findings.</p></sec><sec id="deo2398-sec-0060"><title>METHODS</title><sec id="deo2398-sec-0070"><title>Participants</title><p>This retrospective study included all 8,358 adult individuals who underwent upper gastrointestinal endoscopy for abdominal symptoms or gastric cancer monitoring at Hamamatsu University Hospital between January 2017 and May 2022. Exclusions were made for cases involving postoperative stomach evaluations and instances of poor observation quality. The study was approved by the Institutional Review Board of the Hamamatsu University School of Medicine (approval no. 22&#x02010;014, 23&#x02013;239), which confirmed that the study complied with the ethical guidelines of the Helsinki Declaration.</p></sec><sec id="deo2398-sec-0080"><title>Demographic and clinical profiles</title><p>We collected data related to age, gender, pharmaceutical regimen, blood test results within 3 months prior to endoscopy, <italic toggle="yes">H. pylori</italic> infection status, and the detection of BSs in the gastric region during endoscopy from patient medical records. Medications were categorized as those administered consistently for a minimum of 1 month, extending back 2 years from the date of endoscopy. The medication categories included H2 blockers, PPIs (vonoprazan and other PPIs), statins, corticosteroids, antiplatelet agents, anticoagulants, and iron preparations (drug details are summarized in Table <xref rid="deo2398-supitem-0001" ref-type="supplementary-material">S1</xref>). Regarding hematological evaluations, data for serum creatinine, hemoglobin, serum iron, serum ferritin, total cholesterol, and HbA1c were collected from the patient's medical records.</p></sec><sec id="deo2398-sec-0090"><title>Endoscopic assessment</title><p>For patients who met the inclusion criteria, all recorded endoscopic images were reviewed for the detection of BSs. The presence or absence of BSs was collaboratively determined by three experienced endoscopists through discussion. Cases in which differentiation between hematin and BS was difficult in the lentigo findings were excluded. Patients with &#x02265;10 spots were classified into the diffuse group and those with &#x0003c;10 spots were defined as the non&#x02010;diffuse group. We evaluated the degree of gastric mucosal atrophy using the Kimura&#x02013;Takemoto classification and categorized it as follows: C&#x02010;0 and C&#x02010;1 for no atrophy; C&#x02010;2 and C&#x02010;3 for closed atrophy; O&#x02010;1, O&#x02010;2, and O&#x02010;3 for opened atrophy.<xref rid="deo2398-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="deo2398-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>
</p></sec><sec id="deo2398-sec-0100"><title>
<italic toggle="yes">H. pylori</italic> Infection Status</title><p>The determination of <italic toggle="yes">H. pylori</italic> infection status was based on a combination of rapid urease test, urea breath test, stool antigen test, and biopsy culture results, alongside the patient's history of eradication treatment. According to previous research, cases exhibiting atrophic gastric mucosa alongside positive test results were classified as current <italic toggle="yes">H. pylori</italic> infections.<xref rid="deo2398-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="deo2398-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="deo2398-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> In contrast, those with a history of eradication therapy or those exhibiting mucosal atrophy alongside negative test outcomes were categorized as post&#x02010;eradication cases. Cases without a history of eradication therapy and with a regular arrangement of collecting venules observed in the gastric angle were counted as uninfected.</p></sec><sec id="deo2398-sec-0110"><title>NanoSuit&#x02010;CLEM Method Combined with SEM&#x02010;EDS</title><p>We performed histopathological analysis using hematoxylin and eosin staining on biopsy and surgical specimens of cases where BSs were observed. For specimens with brownish substance deposits detected by the hematoxylin and eosin staining and suspected of BS, the NanoSuit&#x02010;CLEM method combined with SEM&#x02010;EDS was further used. The procedure involved deparaffinizing the sections with xylene and rehydration with a surface shield enhancer (SSE) solution.<xref rid="deo2398-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="deo2398-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> The sections were then centrifuged at 2000 rpm for 15 s, facilitating the spin&#x02010;coating of the sections and the removal of surplus SSE solution. Post&#x02010;centrifugation, the samples were immediately introduced into the SEM and exposed to an electron beam to induce the formation of NanoSuit. Elemental composition was analyzed employing an SEM (TM4000Plus; HITACHI; accelerating voltage: 15 kV) outfitted with EDS (X&#x02010;stream&#x02010;2; Oxford Instruments). The EDS analysis was conducted using AZtecOne software (Oxford Instruments).</p><p>EDS analysis was performed on glandular ducts with BS, dilated glandular ducts without BS, and normal mucosa. The weight concentration of each detected element was quantified and articulated as a weight percent (wt%), delineating the relative concentration of the element within the analyzed area. Comparative analysis of wt% across different regions was executed.</p></sec><sec id="deo2398-sec-0120"><title>Statistical evaluation</title><p>All statistical evaluations were conducted using EZR (Saitama Medical Center, Jichi Medical University).<xref rid="deo2398-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> The Mann&#x02013;Whitney U and Fisher's exact probability tests were used to compare patient backgrounds between those with and without BSs. Variables identified as significant in the univariate analysis were incorporated into a multivariate model, and independent risk factors associated with the presence of BSs were determined through logistic regression analysis.</p><p>The wt% data derived from the EDS analysis were statistically scrutinized utilizing the Mann&#x02013;Whitney U test. We determined that the results were statistically significant if the <italic toggle="yes">p</italic>&#x02010;value was below 0.05.</p></sec></sec><sec id="deo2398-sec-0130"><title>RESULTS</title><sec id="deo2398-sec-0140"><title>Patient background</title><p>During the study period, 8358 patients underwent upper gastrointestinal endoscopy. Of these, 6778 were considered eligible for analysis after excluding 794 patients with poor observation and 786 patients after gastrectomy (Figure&#x000a0;<xref rid="deo2398-fig-0001" ref-type="fig">1</xref>). The demographics of these patients are detailed in Table&#x000a0;<xref rid="deo2398-tbl-0001" ref-type="table">1</xref>. The cohort comprised 42.3% female patients, with an average age of 69 years (interquartile range [IQR], 57&#x02013;76 years). Among them, 482 patients (7.1%) had BSs, with 192 (39.8%) categorized into the diffuse group and 290 (60.2%) into the non&#x02010;diffuse group. During the examination of BS locations, 82.0% (395 out of 482) were located in normal mucosal sites, 10.4% (50 out of 482) were situated within fundic gland polyps, and 7.7% (37 out of 482) were found in both normal mucosa and fundic gland polyps.</p><fig position="float" fig-type="FIGURE" id="deo2398-fig-0001"><label>FIGURE 1</label><caption><p>Flow chart of patients recruited in this study. EGD, esophagogastroduodenoscopy.</p></caption><graphic xlink:href="DEO2-5-e398-g003" position="anchor" id="jats-graphic-1"/></fig><table-wrap position="float" id="deo2398-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Characteristics of patients.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Overall, <italic toggle="yes">n</italic> = 6778</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Sex, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Male</td><td align="char" rowspan="1" colspan="1">3912 (57.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Female</td><td align="char" rowspan="1" colspan="1">2866 (42.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Age, years (median [IQR])</td><td align="char" rowspan="1" colspan="1">69.0 (57.0&#x02013;76.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">H2 blocker use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">381 (5.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">PPI use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">2084 (30.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Vonoprazan, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">303 (4.5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">PPIs (excluding vonoprazan), <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">1050 (15.5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Both drugs, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">731 (10.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Statin use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">949 (14.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Corticosteroid use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">373 (5.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Antiplatelet drug use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">143 (2.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Anticoagulant drug use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">359 (5.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Iron preparation use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">290 (4.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Atrophic border, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">None</td><td align="char" rowspan="1" colspan="1">3126 (46.4)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Closed&#x02010;type</td><td align="char" rowspan="1" colspan="1">1523 (22.6)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Open&#x02010;type</td><td align="char" rowspan="1" colspan="1">2086 (31.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hp infection status, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">None</td><td align="char" rowspan="1" colspan="1">3063 (45.2)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Past infection</td><td align="char" rowspan="1" colspan="1">1455 (21.5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Current infection</td><td align="char" rowspan="1" colspan="1">623 (9.2)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unknown</td><td align="char" rowspan="1" colspan="1">1637 (24.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Cr, mg/dL (median [IQR])<xref rid="deo2398-tbl1-note-0002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="char" rowspan="1" colspan="1">0.8 (0.7&#x02013;1.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hb, g/dL (median [IQR])<xref rid="deo2398-tbl1-note-0002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="char" rowspan="1" colspan="1">12.9 (11.2&#x02013;14.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum iron, &#x000b5;g/dL (median [IQR])<xref rid="deo2398-tbl1-note-0002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="char" rowspan="1" colspan="1">70.0 (43.00&#x02013;100.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum ferritin, ng/mL (median [IQR])<xref rid="deo2398-tbl1-note-0002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="char" rowspan="1" colspan="1">48.0 (20.0&#x02013;126.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Chol, mg/dL (median [IQR])<xref rid="deo2398-tbl1-note-0002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="char" rowspan="1" colspan="1">189.0 (164.0&#x02013;216.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">HbA1c, % (median [IQR])<xref rid="deo2398-tbl1-note-0002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="char" rowspan="1" colspan="1">5.9 (5.6&#x02013;6.5)</td></tr></tbody></table><table-wrap-foot><fn id="deo2398-tbl1-note-0001"><p>Abbreviations: Chol, cholesterol; Cr, creatinine; Hb, hemoglobin; HbA1c, hemoglobin A1c; Hp, <italic toggle="yes">Helicobacter pylori</italic>; IQR, interquartile range; PPI, proton pump inhibitor.</p></fn><fn id="deo2398-tbl1-note-0002"><label>
<sup>&#x02020;</sup>
</label><p>The test values displayed are based on measurements from the following number of patients: Cr from 5789, Hb from 5830, serum iron from 1085, serum ferritin from 650, chol from 2601, and HbA1c from 2220 patients. Patients whose data is not shown did not undergo the testing, and the data were not collected.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo2398-sec-0150"><title>Univariate analysis</title><p>As shown in Table&#x000a0;<xref rid="deo2398-tbl-0002" ref-type="table">2</xref>, several findings were observed in the univariate analysis comparing patients with gastric BSs and those without gastric BSs. Individuals with BSs were generally older, with a median age of 75.0 years (IQR: 68.0&#x02013;80.0) as opposed to 69.0 years (IQR: 55.0&#x02013;76.0) for those without BSs (<italic toggle="yes">p</italic> &#x0003c; 0.001). Regarding medication, the usage of PPIs, statins, and corticosteroids was notably higher in the group with BSs (54.4% vs. 28.9%, 29.3% vs. 12.8%, and 11.6% vs. 5.0%, respectively; all <italic toggle="yes">p</italic> &#x0003c; 0.001). Similarly, the intake of antiplatelet drugs, anticoagulants, and iron supplements was more prevalent in this group (8.7% vs. 1.6%, 17.6% vs. 4.4%, and 8.5% vs. 4.0%, respectively; all <italic toggle="yes">p</italic> &#x0003c; 0.001). Comparing the use of vonoprazan and other PPIs, it was found that in cases with BSs, the use of vonoprazan alone, PPIs (excluding vonoprazan), and both drugs were 4.3%, 27.0%, and 23.0% (21/130/111), respectively. In contrast, in cases without BSs, the rates were 4.5%, 14.6%, and 9.8% (282/920/620), respectively, indicating a significant association between the use of PPIs other than vonoprazan and the presence of BSs. In terms of laboratory testing, patients with BSs exhibited higher serum creatinine (0.9 vs. 0.8 mg/dL; <italic toggle="yes">p</italic> &#x0003c; 0.001) and lower hemoglobin levels (12.4 vs. 12.9 g/dL; <italic toggle="yes">p</italic> &#x0003c; 0.001), while no significant differences were observed for serum iron and serum ferritin (<italic toggle="yes">p</italic> = 0.6 and <italic toggle="yes">p</italic> = 0.3 respectively). Additionally, endoscopic findings indicated a higher prevalence of gastric atrophy in patients with BSs at 66.8%, compared with 52.6% in those without BSs, and a lower occurrence of current <italic toggle="yes">H. pylori</italic> infection in the patients with BSs at 1.0% vs. 9.8% in those without BSs, with both observations showing statistical significance (<italic toggle="yes">p</italic> &#x0003c; 0.001). The subgroup analysis of the diffuse group (those with &#x0003e;10 BSs in the stomach) indicated a higher degree of atrophy (open type/closed type/none: 44.3%/32.8%/22.9% vs. 31.0%/29.0%/40.0%; <italic toggle="yes">p</italic> &#x0003c; 0.001) and a higher prevalence of the diffuse pattern post&#x02010;<italic toggle="yes">H. Pylori</italic> eradication (51.0% vs. 41.0%; <italic toggle="yes">p</italic> = 0.001; Table <xref rid="deo2398-supitem-0001" ref-type="supplementary-material">S2</xref>).</p><table-wrap position="float" id="deo2398-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Comparing patients with and without black spots in univariate analysis.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">BSs present, <italic toggle="yes">n</italic> = 482</th><th align="left" rowspan="1" colspan="1">BSs absent, <italic toggle="yes">n</italic> = 6296</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Sex, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">0.148</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Male</td><td align="char" rowspan="1" colspan="1">299 (62.0)</td><td align="char" rowspan="1" colspan="1">3613 (57.4)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Female</td><td align="char" rowspan="1" colspan="1">183 (38.0)</td><td align="char" rowspan="1" colspan="1">2683 (42.6)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Age, years (median [IQR])</td><td align="char" rowspan="1" colspan="1">75.0 (68.0&#x02013;80.0)</td><td align="char" rowspan="1" colspan="1">69.0 (55.0&#x02013;76.0)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">H2 blocker use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">39 (8.1)</td><td align="char" rowspan="1" colspan="1">342 (5.4)</td><td align="char" rowspan="1" colspan="1">0.018</td></tr><tr><td align="left" rowspan="1" colspan="1">PPI use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">262 (54.4)</td><td align="char" rowspan="1" colspan="1">1822 (28.9)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Vonoprazan, n (%)</td><td align="char" rowspan="1" colspan="1">21 (4.3)</td><td align="char" rowspan="1" colspan="1">282 (4.5)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">PPIs (excluding vonoprazan), <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">130 (27.0)</td><td align="char" rowspan="1" colspan="1">920 (14.6)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Both drugs, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">111 (23.0)</td><td align="char" rowspan="1" colspan="1">620 (9.8)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Statin use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">141 (29.3)</td><td align="char" rowspan="1" colspan="1">808 (12.8)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Corticosteroid use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">56 (11.6)</td><td align="char" rowspan="1" colspan="1">317 (5.0)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Antiplatelet drug use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">42 (8.7)</td><td align="char" rowspan="1" colspan="1">101 (1.6)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Anticoagulant drug use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">85 (17.6)</td><td align="char" rowspan="1" colspan="1">274 (4.4)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Iron preparation use, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">41 (8.5)</td><td align="char" rowspan="1" colspan="1">249 (4.0)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Atrophic border, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">None</td><td align="char" rowspan="1" colspan="1">160 (33.2)</td><td align="char" rowspan="1" colspan="1">2966 (47.4)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Closed&#x02010;type</td><td align="char" rowspan="1" colspan="1">147 (30.5)</td><td align="char" rowspan="1" colspan="1">1376 (22.0)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Open&#x02010;type</td><td align="char" rowspan="1" colspan="1">175 (36.3)</td><td align="char" rowspan="1" colspan="1">1911 (30.6)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Hp infection status, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">None</td><td align="char" rowspan="1" colspan="1">158 (32.8)</td><td align="char" rowspan="1" colspan="1">2905 (46.1)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Past infection</td><td align="char" rowspan="1" colspan="1">217 (45.0)</td><td align="char" rowspan="1" colspan="1">1238 (19.7)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Current infection</td><td align="char" rowspan="1" colspan="1">5 (1.0)</td><td align="char" rowspan="1" colspan="1">618 (9.8)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unknown</td><td align="char" rowspan="1" colspan="1">102 (21.2)</td><td align="char" rowspan="1" colspan="1">1535 (24.4)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cr, mg/dL (median [IQR])<xref rid="deo2398-tbl2-note-0002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="char" rowspan="1" colspan="1">0.9 (0.7&#x02013;1.3)</td><td align="char" rowspan="1" colspan="1">0.8 (0.7&#x02013;1.0)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Hb, g/dL (median [IQR])<xref rid="deo2398-tbl2-note-0002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="char" rowspan="1" colspan="1">12.4 (10.6&#x02013;13.8)</td><td align="char" rowspan="1" colspan="1">12.9 (11.2&#x02013;14.2)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum iron, &#x000b5;g/dL (median [IQR])<xref rid="deo2398-tbl2-note-0002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="char" rowspan="1" colspan="1">68.0 (40.5&#x02013;96.5)</td><td align="char" rowspan="1" colspan="1">70.0 (43.0&#x02013;100.8)</td><td align="char" rowspan="1" colspan="1">0.641</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum ferritin, ng/mL (median [IQR])<xref rid="deo2398-tbl2-note-0002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="char" rowspan="1" colspan="1">57.0 (22.0&#x02013;193.0)</td><td align="char" rowspan="1" colspan="1">48.0 (19.0&#x02013;120.0)</td><td align="char" rowspan="1" colspan="1">0.328</td></tr><tr><td align="left" rowspan="1" colspan="1">Chol, mg/dL (median [IQR])<xref rid="deo2398-tbl2-note-0002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="char" rowspan="1" colspan="1">188.0 (160.0&#x02013;218.3)</td><td align="char" rowspan="1" colspan="1">191.0 (164.0&#x02013;216.0)</td><td align="char" rowspan="1" colspan="1">0.416</td></tr><tr><td align="left" rowspan="1" colspan="1">HbA1c, % (median [IQR])<xref rid="deo2398-tbl2-note-0002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="char" rowspan="1" colspan="1">6.0 (5.6&#x02013;6.6)</td><td align="char" rowspan="1" colspan="1">5.9 (5.6&#x02013;6.5)</td><td align="char" rowspan="1" colspan="1">0.259</td></tr></tbody></table><table-wrap-foot><fn id="deo2398-tbl2-note-0001"><p>Abbreviations: Chol, cholesterol; Cr, creatinine; Hb, hemoglobin; HbA1c, hemoglobin A1c; Hp, <italic toggle="yes">Helicobacter pylori</italic>; IQR, interquartile range; PPI, proton pump inhibitor.</p></fn><fn id="deo2398-tbl2-note-0002"><label>
<sup>&#x02020;</sup>
</label><p>The test values displayed are based on measurements from the following number of patients: Cr from 400/5389 (with/without BSs), Hb from 404/5426, serum iron from 71/1014, serum ferritin from 51/599, chol from 200/2401, and HbA1c from 172/2048 patients. Patients whose data is not shown did not undergo the testing, and the data were not collected.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo2398-sec-0160"><title>Multivariate analysis</title><p>In the multivariate analysis, which was built upon the univariate findings, patient data were stratified by clinically significant benchmarks, such as aged &#x02265;70 years, creatinine levels &#x0003e;1.5 mg/dL indicative of chronic renal failure, and hemoglobin levels &#x0003c;11 g/dL suggestive of anemia. The multivariate analysis extracted several risk factors for the presence of BSs in the stomach (Figure&#x000a0;<xref rid="deo2398-fig-0002" ref-type="fig">2</xref> and Table <xref rid="deo2398-supitem-0001" ref-type="supplementary-material">S3</xref>). Specifically, those aged &#x02265;70 years (odds ratio [OR] 2.13; 95% confidence interval [CI] 1.70&#x02013;2.67) and use of PPIs (OR 2.15; 95% CI 1.74&#x02013;2.66), statins (OR 1.72; 95% CI 1.36&#x02013;2.18), corticosteroids (OR 2.13; 95% CI 1.53&#x02013;2.96), antiplatelets (OR 3.32; 95% CI 2.21&#x02013;4.98), and anticoagulants (OR 2.48; 95% CI 1.84&#x02013;3.35) were all significant for the presence of BSs. Additionally, a previous history of <italic toggle="yes">H. pylori</italic> infection was a notable risk factor for the presence of BSs (OR 2.79; 95% CI 2.21&#x02013;3.53), whereas an ongoing <italic toggle="yes">H. pylori</italic> infection appeared to reduce the risk of BSs (OR 0.15; 95% CI 0.06&#x02013;0.36). Elevated creatinine levels (&#x0003e;1.5 mg/dL) were also linked to an increased risk of BSs in the stomach (OR 1.69; 95% CI 1.26&#x02013;2.27).</p><fig position="float" fig-type="FIGURE" id="deo2398-fig-0002"><label>FIGURE 2</label><caption><p>Multivariate analysis comparing the patient outcomes with and without black spots. IQR, interquartile range; PPI, proton pump inhibitor; Hp, <italic toggle="yes">Helicobacter pylori</italic>; Cr, creatinine; Hb, hemoglobin; OR, odds ratio; CI, confidence interval.</p></caption><graphic xlink:href="DEO2-5-e398-g005" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="deo2398-sec-0170"><title>NanoSuit method proved localization of iron</title><p>Among the patients with endoscopically observed BSs, biopsies were taken from the BSs in 10, and surgical treatment was performed in 35. Of these, 11 patients exhibited brownish deposits within the dilated fundus gland (Table&#x000a0;<xref rid="deo2398-tbl-0003" ref-type="table">3</xref> and Figure&#x000a0;<xref rid="deo2398-fig-0003" ref-type="fig">3</xref>). Specifically, these instances comprised five cases within fundic gland polyps against a familial adenomatous polyposis background, one within gastric adenocarcinoma of fundic&#x02010;gland type, three within other fundic gland polyps, and two within normal mucosa.</p><table-wrap position="float" id="deo2398-tbl-0003" content-type="TABLE"><label>TABLE 3</label><caption><p>Background characteristics of patients undergoing the NanoSuit&#x02010;correlative light and electron microscopy method.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Case no.</th><th align="left" rowspan="1" colspan="1">Sex</th><th align="left" rowspan="1" colspan="1">Age</th><th align="left" rowspan="1" colspan="1">Endoscopic deposited area</th><th align="left" rowspan="1" colspan="1">Background disease</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">H. pylori</italic> eradication</th><th align="left" rowspan="1" colspan="1">PPIs</th><th align="left" rowspan="1" colspan="1">Statins</th><th align="left" rowspan="1" colspan="1">Corticosteroids</th><th align="left" rowspan="1" colspan="1">Antiplatelet drugs</th><th align="left" rowspan="1" colspan="1">Anticoagulant drugs</th><th align="left" rowspan="1" colspan="1">Tissue sample</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">FGP</td><td align="left" rowspan="1" colspan="1">FAP</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Ope</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1">FGP</td><td align="left" rowspan="1" colspan="1">FAP</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Ope</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">FGP</td><td align="left" rowspan="1" colspan="1">FAP</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Ope</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">66</td><td align="left" rowspan="1" colspan="1">FGP</td><td align="left" rowspan="1" colspan="1">FAP</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Ope</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">48</td><td align="left" rowspan="1" colspan="1">FGP</td><td align="left" rowspan="1" colspan="1">FAP</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Ope</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">71</td><td align="left" rowspan="1" colspan="1">Tumor</td><td align="left" rowspan="1" colspan="1">GA&#x02010;FG</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Ope</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">72</td><td align="left" rowspan="1" colspan="1">Normal mucosa</td><td align="left" rowspan="1" colspan="1">EGJC</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Ope</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">76</td><td align="left" rowspan="1" colspan="1">FGP</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">EMR</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">83</td><td align="left" rowspan="1" colspan="1">Normal mucosa</td><td align="left" rowspan="1" colspan="1">GC</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Ope</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">82</td><td align="left" rowspan="1" colspan="1">FGP</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">biopsy</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">75</td><td align="left" rowspan="1" colspan="1">FGP</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">biopsy</td></tr></tbody></table><table-wrap-foot><fn id="deo2398-tbl3-note-0001"><p>Abbreviations: EGJC, esophagogastric junction cancer; EMR, endoscopic mucosal resection; FAP, familial adenomatous polyposis; FGP, fundic gland polyp; GA&#x02010;FG, gastric adenocarcinoma of fundic gland type; GC, gastric cancer; Ope, surgical operation; PPI, proton pump inhibitor.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><fig position="float" fig-type="FIGURE" id="deo2398-fig-0003"><label>FIGURE 3</label><caption><p>Endoscopic and optical microscopic findings of black spots. Images in the left column are endoscopic images of black spots. Cases 4 and 5 show black spots inside fundic gland polyps, and Case 6 shows black spots inside gastric adenocarcinoma of fundic gland type. The image in the right column is from a light microscope. Brownish deposits are seen inside the fundic gland cysts. Scale bar = 250 &#x000b5;m.</p></caption><graphic xlink:href="DEO2-5-e398-g002" position="anchor" id="jats-graphic-5"/></fig><p>The regions containing the brown deposits were examined using the NanoSuit&#x02010;CLEM method. The backscattered SEM images consistently revealed granular, bright contrast areas in all cases (Figure&#x000a0;<xref rid="deo2398-fig-0003" ref-type="fig">3</xref> and Figure <xref rid="deo2398-supitem-0001" ref-type="supplementary-material">S1</xref>). Notably, elemental mapping via SEM&#x02010;EDS pinpointed the presence of iron (Fe) in these areas. Moreover, the weight percent (wt%) of iron within the BS regions was significantly higher compared to the background, and interestingly, iron localization was not observed in dilated gland ducts or normal mucosa without BSs (Figures&#x000a0;<xref rid="deo2398-fig-0004" ref-type="fig">4</xref> and&#x000a0;<xref rid="deo2398-fig-0005" ref-type="fig">5</xref>). The distribution of elements other than iron is detailed in Table <xref rid="deo2398-supitem-0001" ref-type="supplementary-material">S4</xref>.</p><fig position="float" fig-type="FIGURE" id="deo2398-fig-0004"><label>FIGURE 4</label><caption><p>Visualization of deposits in fundic gland cysts using scanning electron microscopy&#x02010;energy dispersive X&#x02010;ray spectroscopy analysis with the NanoSuit&#x02010;correlative light and electron microscopy method. Images in the left column are backscattered scanning electron microscopy images showing bright areas in the deposits. The right column images are elemental mapping images using the NanoSuit&#x02010;correlative light and electron microscopy) method combined with scanning electron microscopy&#x02010;energy dispersive X&#x02010;ray spectroscopy analysis showing iron deposition.</p></caption><graphic xlink:href="DEO2-5-e398-g004" position="anchor" id="jats-graphic-7"/></fig><fig position="float" fig-type="FIGURE" id="deo2398-fig-0005"><label>FIGURE 5</label><caption><p>Comparison of iron weight percent in the black spots. Spectral analysis between bright area (B), fundic gland cysts (C), and normal mucosa (M) by SEM&#x02010;EDS (scanning electron microscopy&#x02010;energy dispersive X&#x02010;ray spectroscopy) using the NanoSuit&#x02010;CLEM (correlative light and electron microscopy) method. A comparison of the weight percentage (wt%) of iron is obtained by spectrum analysis.</p></caption><graphic xlink:href="DEO2-5-e398-g001" position="anchor" id="jats-graphic-9"/></fig></sec></sec><sec id="deo2398-sec-0180"><title>DISCUSSION</title><p>In this research, we conducted a comprehensive analysis of patients with BSs in the stomach and demonstrated that a) BSs are less likely to occur in the presence of active <italic toggle="yes">H.pylori</italic> infection and b) iron is specifically deposited within BSs. To our knowledge, these findings are being reported for the first time, marking a significant contribution to understanding BSs in the stomach.</p><p>The clinicopathological analysis revealed that 7.1% of the patients undergoing upper gastrointestinal endoscopy exhibited gastric BSs. These BSs were particularly prevalent among specific patient groups, manifesting in 12.6% (262 out of 2084) of those on PPIs and 14.9% (217 out of 1455) of patients post&#x02010;<italic toggle="yes">H. Pylori</italic> eradication. Conversely, BSs were present in only 0.8% (five out of 623) of patients with active <italic toggle="yes">H. pylori</italic> infection, particularly in only 0.5% (one out of 192) of patients with diffuse BSs. The observed pattern in the study suggests that the presence of gastric BSs might indicate inactive or absent <italic toggle="yes">H. pylori</italic>&#x02010;related inflammation. This relationship proposes that BSs could potentially serve as a non&#x02010;invasive clinical marker for <italic toggle="yes">H. pylori</italic> inflammation, identifiable through endoscopic observation. Furthermore, when comparing vonoprazan with PPIs, it was observed that PPIs were significantly more likely to be associated with BSs. Specifically, 12.3% (130 out of 1050) of patients on PPIs alone experienced BSs compared with 6.9% (21 out of 303) of patients on vonoprazan alone. These findings align with those from the VISION trial and suggest that the differing likelihood of BS occurrence between PPIs and vonoprazan could stem from variations in their mechanisms of acid suppression.<xref rid="deo2398-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>
</p><p>The etiology behind gastric BSs has been elusive, but this study sheds light on potential mechanisms. First, dilation of the gastric fundic glands appears to be a precursor, potentially initiated by hypergastrinemia due to PPI use. This condition is hypothesized to induce morphological alterations in gastric wall cells, leading to obstruction at the narrowed sections, increased outflow resistance, and, consequently, cystic dilation of the gastric fundic glands.<xref rid="deo2398-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="deo2398-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="deo2398-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> PPI usage has also been associated with heightened expression of aquaporin&#x02010;4 in the wall cells from the basal to the narrow part of the fundus gland, potentially facilitating water migration into the gland lumen, promoting gastric fundus gland dilation, and inducing morphological changes in gastric wall cells.<xref rid="deo2398-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="deo2398-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> Moreover, corticosteroid administration and renal impairment, known to elevate serum gastrin levels, might contribute to gastric fundic gland dilation.<xref rid="deo2398-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="deo2398-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> It is also posited that proteases incited by <italic toggle="yes">H. pylori</italic> infection may expedite the degradation and efflux of gastric mucus, impeding cystic dilation.<xref rid="deo2398-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Consistent with this notion, the current study observed a diminished risk of BSs in association with <italic toggle="yes">H. pylori</italic> infection, aligning with the hypothesis that <italic toggle="yes">H. pylori</italic> eradication restores basal gastric gland function and enhances gastric acid secretion, potentially leading to fundic gland dilation.<xref rid="deo2398-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>, <xref rid="deo2398-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>
</p><p>Secondly, iron deposition in the dilated fundic gland is noted. The presence of iron in gastric juice is a well&#x02010;documented phenomenon, and prolonged retention of gastric juice within the dilated fundus gland might amplify the iron concentration, leading to its precipitation.<xref rid="deo2398-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>, <xref rid="deo2398-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> Hemorrhage within the dilated fundus gland could further escalate iron levels. This theory is corroborated by the increased risk of BSs associated with antithrombotic drug use. Additionally, statin usage, implicated in inducing ferroptosis and iron accumulation in adipocytes and cardiomyocytes, may similarly provoke iron accumulation in gastric mucosal cells, contributing to elevated iron concentrations in cysts.<xref rid="deo2398-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>, <xref rid="deo2398-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>
</p><p>In prior research where the NanoSuit&#x02010;CLEM method was applied to pathological specimens with siderosis, intracellular iron deposition was confirmed.<xref rid="deo2398-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> This type of iron deposition is also characteristic of diseases like hemochromatosis, which involves extensive iron accumulation primarily in hepatocytes, and aceruloplasminemia, where iron predominantly accumulates in the neuronal cells of the brain.<xref rid="deo2398-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>, <xref rid="deo2398-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> These disorders are marked by iron accumulation within cells. However, conditions leading to iron deposition within luminal spaces, as seen in the case of BSs, are relatively rare. This contrast highlights the uniqueness of the iron deposition pattern observed in BSs, differing significantly from the more common intracellular iron accumulation in other pathologies.</p><p>This research provides valuable insights but also has inherent limitations. The findings from this highly specialized, single&#x02010;center, retrospective study, conducted at a university hospital, may have limited generalizability. The analysis was confined to stored endoscopic images, potentially leading to an underestimation of the actual prevalence of BSs in areas where images were not archived. The medication histories, while meticulously extracted from medical records, might not entirely capture the patients' full medication profiles. Furthermore, consistent with previous research, endoscopic biopsies from areas with BSs frequently result in unclear pathological findings.<xref rid="deo2398-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> This trend was also observed in the current study. Most cases (nine out of 11) subjected to the NanoSuit&#x02010;CLEM method were based on surgical resections. This reliance on surgically resected specimens instead of biopsy samples might influence the study findings. Despite these challenges, the uniform detection of iron in all cases examined with the NanoSuit&#x02010;CLEM method is a significant and noteworthy discovery.</p></sec><sec id="deo2398-sec-0190"><title>CONCLUSIONS</title><p>The study results suggest a negative correlation between the presence of BSs and active <italic toggle="yes">H. pylori</italic> infection. Consistent with previous findings, PPIs and a history of <italic toggle="yes">H. pylori</italic> eradication have been identified as risk factors. Additionally, this study has revealed that antithrombotic drug use also poses a risk. A critical aspect of this research is the use of the NanoSuit&#x02010;CLEM method combined with SEM&#x02010;EDS, which has successfully detected iron deposition within these BSs. This discovery provides significant insights into the potential causes of these BSs.</p></sec><sec sec-type="COI-statement" id="deo2398-sec-0210"><title>CONFLICT OF INTEREST STATEMENT</title><p>None.</p></sec><sec id="deo2398-sec-0220"><title>ETHICS STATEMENT</title><p>The study was approved by the Institutional Review Board of the Hamamatsu University School of Medicine (approval no. 22&#x02010;014, 23&#x02013;239), which confirmed that the study complied with the ethical guidelines of the Helsinki Declaration.</p></sec><sec id="deo2398-sec-0230"><title>PATIENT CONSENT STATEMENT</title><p>Written informed consent was obtained from patients for participation in the study. In situations where obtaining written consent was not feasible, an opt&#x02010;out procedure was implemented to ensure ethical compliance and respect for patient autonomy.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="deo2398-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>TABLE S1</bold>: Drug class and medication name.</p><p>
<bold>TABLE S2</bold>: Univariate analysis comparing whether the black spots are diffuse or not.</p><p>
<bold>TABLE S3</bold>: Multivariate analysis comparing the patient outcomes with and without black spots.</p><p>
<bold>TABLE S4</bold>: List of weight percentage (wt%) of elements detected by SEM&#x02010;EDS analysis using the NanoSuit&#x02010;CLEM method.</p><p>
<bold>FIGURE S1</bold>: Visualization of deposits in fundic gland cysts using SEM&#x02010;EDS analysis with the NanoSuit&#x02010;CLEM method.</p></caption><media xlink:href="DEO2-5-e398-s001.docx"/></supplementary-material></sec></body><back><ack id="deo2398-sec-0200"><title>ACKNOWLEDGMENTS</title><p>Part of this work was performed at the Advanced Research Facilities &#x00026; Services (ARFS), Hamamatsu University School of Medicine. This work was supported by the Japan Society for the Promotion of Science (JSPS) (KAKENHI Grant Number 22K08053 to M.I.).</p></ack><ref-list id="deo2398-bibl-0001"><title>REFERENCES</title><ref id="deo2398-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo2398-cit-0001">
<string-name>
<surname>Hatano</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Haruma</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ayaki</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Black spot, a novel gastric finding potentially induced by proton pump inhibitors</article-title>. <source>Intern Med</source>
<year>2016</year>; <volume>55</volume>: <fpage>3079</fpage>&#x02013;<lpage>3084</lpage>.<pub-id pub-id-type="pmid">27803398</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo2398-cit-0002">
<string-name>
<surname>Hatano</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Haruma</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kamada</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Factors associated with gastric black spot, white flat elevated mucosa, and cobblestone&#x02010;like mucosa: A cross&#x02010;sectional study</article-title>. <source>Digestion</source>
<year>2018</year>; <volume>98</volume>: <fpage>185</fpage>&#x02013;<lpage>193</lpage>.<pub-id pub-id-type="pmid">29870991</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo2398-cit-0003">
<string-name>
<surname>Adachi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Notsu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mishiro</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kinoshita</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Relationship of <italic toggle="yes">Helicobacter pylori</italic> infection with gastric black spots shown by endoscopy</article-title>. <source>Intern Med</source>
<year>2019</year>; <volume>58</volume>: <fpage>767</fpage>&#x02013;<lpage>772</lpage>.<pub-id pub-id-type="pmid">30449800</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo2398-cit-0004">
<string-name>
<surname>Nakagawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Abe</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Takada</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic features of gastric adenocarcinoma of fundic gland type</article-title>. <source>Stomach Intestine</source>
<year>2015</year>; <volume>50</volume>: <fpage>1521</fpage>&#x02013;<lpage>1531</lpage>.</mixed-citation></ref><ref id="deo2398-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo2398-cit-0005">
<string-name>
<surname>Sato</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Fujino</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kasagawa</surname>
<given-names>A</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Twelve&#x02010;year natural history of a gastric adenocarcinoma of fundic gland type</article-title>. <source>Clin J Gastroenterol</source>
<year>2016</year>; <volume>9</volume>: <fpage>345</fpage>&#x02013;<lpage>351</lpage>.<pub-id pub-id-type="pmid">27624750</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo2398-cit-0006">
<string-name>
<surname>Shioya</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Terahata</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Nakajima</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Recurrence of gastric adenocarcinoma of fundic&#x02010;gland mucosa type with black spots after endoscopic submucosal dissection and oral proton pump inhibitor discontinuation</article-title>. <source>Pathol Int</source>
<year>2022</year>; <volume>72</volume>: <fpage>430</fpage>&#x02013;<lpage>432</lpage>.<pub-id pub-id-type="pmid">35723501</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo2398-cit-0007">
<string-name>
<surname>Takaku</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ohta</surname>
<given-names>I</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>A thin polymer membrane, nano&#x02010;suit, enhancing survival across the continuum between air and high vacuum</article-title>. <source>Proc Natl Acad Sci U S A</source>
<year>2013</year>; <volume>110</volume>: <fpage>7631</fpage>&#x02013;<lpage>7635</lpage>.<pub-id pub-id-type="pmid">23589878</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo2398-cit-0008">
<string-name>
<surname>Takaku</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kawasaki</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>A modified &#x0201c;NanoSuit&#x000ae;&#x0201d; preserves wet samples in high vacuum: Direct observations on cells and tissues in field&#x02010;emission scanning electron microscopy</article-title>. <source>R Soc Open Sci</source>
<year>2017</year>; <volume>4</volume>: <elocation-id>160887</elocation-id>.<pub-id pub-id-type="pmid">28405375</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo2398-cit-0009">
<string-name>
<surname>Kawasaki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Itoh</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Takaku</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>The NanoSuit method: A novel histological approach for examining paraffin sections in a nondestructive manner by correlative light and electron microscopy</article-title>. <source>Lab Invest</source>
<year>2020</year>; <volume>100</volume>: <fpage>161</fpage>&#x02013;<lpage>173</lpage>.<pub-id pub-id-type="pmid">31467424</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo2398-cit-0010">
<string-name>
<surname>Shinmura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kawasaki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Baba</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Utility of scanning electron microscopy elemental analysis using the &#x0201c;NanoSuit&#x0201d; correlative light and electron microscopy method in the diagnosis of lanthanum phosphate deposition in the esophagogastroduodenal mucosa</article-title>. <source>Diagnostics</source>
<year>2019</year>; <volume>10</volume>: <elocation-id>1</elocation-id>.<pub-id pub-id-type="pmid">31861386</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="deo2398-cit-0011">
<string-name>
<surname>Kimura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Takemoto</surname>
<given-names>T</given-names>
</string-name>. <article-title>An endoscopic recognition of the atrophic border and its significance in chronic gastritis</article-title>. <source>Endoscopy</source>
<year>1969</year>; <volume>1</volume>: <fpage>87</fpage>&#x02013;<lpage>97</lpage>.</mixed-citation></ref><ref id="deo2398-bib-0012"><label>12</label><mixed-citation publication-type="book" id="deo2398-cit-0012">
<string-name>
<surname>Haruma</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Inoue</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Murakami</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kamada</surname>
<given-names>T</given-names>
</string-name>. <source>Kyoto Classification of Gastritis</source>, <publisher-loc>Tokyo</publisher-loc>: <publisher-name>Nihon Medical Center</publisher-name>, <year>2017</year>.</mixed-citation></ref><ref id="deo2398-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="deo2398-cit-0013">
<string-name>
<surname>Kato</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yagi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kamada</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Diagnosis of Helicobacter pylori infection in gastric mucosa by endoscopic features: A multicenter prospective study</article-title>. <source>Dig Endosc</source>
<year>2013</year>; <volume>25</volume>: <fpage>508</fpage>&#x02013;<lpage>518</lpage>.<pub-id pub-id-type="pmid">23369058</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="deo2398-cit-0014">
<string-name>
<surname>Yoshii</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mabe</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Watano</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Validity of endoscopic features for the diagnosis of <italic toggle="yes">Helicobacter pylori</italic> infection status based on the Kyoto classification of gastritis</article-title>. <source>Dig Endosc</source>
<year>2020</year>; <volume>32</volume>: <fpage>74</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="pmid">31309632</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="deo2398-cit-0015">
<string-name>
<surname>Toyoshima</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Nishizawa</surname>
<given-names>T</given-names>
</string-name>. <article-title>Kyoto classification of gastritis: Advances and future perspectives in endoscopic diagnosis of gastritis</article-title>. <source>World J Gastroenterol</source>
<year>2022</year>; <volume>28</volume>: <fpage>6078</fpage>&#x02013;<lpage>6089</lpage>.<pub-id pub-id-type="pmid">36483157</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="deo2398-cit-0016">
<string-name>
<surname>Kanda</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Investigation of the freely available easy&#x02010;to&#x02010;use software &#x0201c;EZR&#x0201d; for medical statistics</article-title>. <source>Bone Marrow Transplant</source>
<year>2013</year>; <volume>48</volume>: <fpage>452</fpage>&#x02013;<lpage>458</lpage>.<pub-id pub-id-type="pmid">23208313</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="deo2398-cit-0017">
<string-name>
<surname>Haruma</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kinoshita</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yao</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Randomised clinical trial: 3&#x02010;year interim analysis results of the VISION trial to evaluate the long&#x02010;term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis</article-title>. <source>BMC Gastroenterol</source>
<year>2023</year>; <volume>23</volume>: <fpage>139</fpage>.<pub-id pub-id-type="pmid">37127558</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="deo2398-cit-0018">
<string-name>
<surname>Cats</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schenk</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Bloemena</surname>
<given-names>E</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment</article-title>. <source>Hum Pathol</source>
<year>2000</year>; <volume>31</volume>: <fpage>684</fpage>&#x02013;<lpage>690</lpage>.<pub-id pub-id-type="pmid">10872661</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="deo2398-cit-0019">
<string-name>
<surname>Fukuda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ishigaki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sugimoto</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Histological analysis of fundic gland polyps secondary to PPI therapy</article-title>. <source>Histopathology</source>
<year>2019</year>; <volume>75</volume>: <fpage>537</fpage>&#x02013;<lpage>545</lpage>.<pub-id pub-id-type="pmid">31087669</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="deo2398-cit-0020">
<string-name>
<surname>Synnerstad</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Holm</surname>
<given-names>L</given-names>
</string-name>. <article-title>Omeprazole induces high intraglandular pressure in the rat gastric mucosa</article-title>. <source>Gastroenterology</source>
<year>1997</year>; <volume>112</volume>: <fpage>1221</fpage>&#x02013;<lpage>1230</lpage>.<pub-id pub-id-type="pmid">9098006</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="deo2398-cit-0021">
<string-name>
<surname>Matsuzaki</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Minegishi</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Acid suppression by proton pump inhibitors enhances aquaporin&#x02010;4 and KCNQ1 expression in gastric fundic parietal cells in mouse</article-title>. <source>Dig Dis Sci</source>
<year>2010</year>; <volume>55</volume>: <fpage>3339</fpage>&#x02013;<lpage>3348</lpage>.<pub-id pub-id-type="pmid">20437101</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="deo2398-cit-0022">
<string-name>
<surname>Naruki</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Fujino</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ohnuma</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Histopathologic and immunohistochemical characterization of human gastric oxyntic mucosa with parietal cell protrusions and investigation into the association between such mucosal changes of the stomach and use of proton pump inhibitors</article-title>. <source>J St Marianna Univ</source>
<year>2015</year>; <volume>6</volume>: <fpage>119</fpage>&#x02013;<lpage>130</lpage>.</mixed-citation></ref><ref id="deo2398-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="deo2398-cit-0023">
<string-name>
<surname>Delaney</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Michel</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Bonsack</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Eisenberg</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Dunn</surname>
<given-names>DH</given-names>
</string-name>. <article-title>Adrenal corticosteroids cause gastrin cell hyperplasia</article-title>. <source>Gastroenterology</source>
<year>1979</year>; <volume>76</volume>: <fpage>913</fpage>&#x02013;<lpage>916</lpage>.<pub-id pub-id-type="pmid">437419</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="deo2398-cit-0024">
<string-name>
<surname>Muto</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Murayama</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Asano</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hosoda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Miyata</surname>
<given-names>M</given-names>
</string-name>. <article-title>Hypergastrinemia and achlorhydria in chronic renal failure</article-title>. <source>Nephron</source>
<year>1985</year>; <volume>40</volume>: <fpage>143</fpage>&#x02013;<lpage>148</lpage>.<pub-id pub-id-type="pmid">4000343</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="deo2398-cit-0025">
<string-name>
<surname>Ito</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Haruma</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kamada</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: A 5&#x02010;year prospective study of patients with atrophic gastritis</article-title>. <source>Aliment Pharmacol Ther</source>
<year>2002</year>; <volume>16</volume>: <fpage>1449</fpage>&#x02013;<lpage>1456</lpage>.<pub-id pub-id-type="pmid">12182744</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="deo2398-cit-0026">
<string-name>
<surname>Toyokawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Suwaki</surname>
<given-names>K&#x02010;I</given-names>
</string-name>, <string-name>
<surname>Miyake</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nakatsu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ando</surname>
<given-names>M</given-names>
</string-name>. <article-title>Eradication of <italic toggle="yes">Helicobacter pylori</italic> infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: A long&#x02010;term prospective cohort study</article-title>. <source>J Gastroenterol Hepatol</source>
<year>2010</year>; <volume>25</volume>: <fpage>544</fpage>&#x02013;<lpage>547</lpage>.<pub-id pub-id-type="pmid">19817964</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="deo2398-cit-0027">
<string-name>
<surname>Kimura</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Yamana</surname>
<given-names>M</given-names>
</string-name>. <article-title>The iron content of gastric juice: In relation to the cause of idiopathic hypochromic anemia</article-title>. <source>Acta Med Okayama (1952)</source>
<year>1967</year>; <volume>21</volume>: <fpage>177</fpage>&#x02013;<lpage>183</lpage>.<pub-id pub-id-type="pmid">4230849</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="deo2398-cit-0028">
<string-name>
<surname>Powell</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Greenfield</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>RP</given-names>
</string-name>. <article-title>Concentrations of metals in gastric juice in health and peptic ulcer disease</article-title>. <source>Gut</source>
<year>1992</year>; <volume>33</volume>: <fpage>1617</fpage>&#x02013;<lpage>1620</lpage>.<pub-id pub-id-type="pmid">1487162</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="deo2398-cit-0029">
<string-name>
<surname>Shu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Statin&#x02010;induced geranylgeranyl pyrophosphate depletion promotes ferroptosis&#x02010;related senescence in adipose tissue</article-title>. <source>Nutrients</source>
<year>2022</year>; <volume>14</volume>: <fpage>4365</fpage>.<pub-id pub-id-type="pmid">36297049</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="deo2398-cit-0030">
<string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Qu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Atorvastatin induces mitochondria&#x02010;dependent ferroptosis via the modulation of Nrf2&#x02010;xCT/GPx4 axis</article-title>. <source>Front Cell Dev Biol</source>
<year>2022</year>; <volume>10</volume>: <elocation-id>806081</elocation-id>.<pub-id pub-id-type="pmid">35309902</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="deo2398-cit-0031">
<string-name>
<surname>Pietrangelo</surname>
<given-names>A</given-names>
</string-name>. <article-title>Hereditary hemochromatosis: Pathogenesis, diagnosis, and treatment</article-title>. <source>Gastroenterology</source>
<year>2010</year>; <volume>139</volume>: <fpage>393</fpage>&#x02013;<lpage>408</lpage>.<pub-id pub-id-type="pmid">20542038</pub-id>
</mixed-citation></ref><ref id="deo2398-bib-0032"><label>32</label><mixed-citation publication-type="book" id="deo2398-cit-0032">
<string-name>
<surname>Miyajima</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hosoi</surname>
<given-names>Y</given-names>
</string-name>. <part-title>Aceruloplasminemia</part-title>. In: <person-group person-group-type="editor">
<string-name>
<surname>Adam</surname>
<given-names>MP</given-names>
</string-name>
</person-group>, <person-group person-group-type="editor">
<string-name>
<surname>Feldman</surname>
<given-names>J</given-names>
</string-name>
</person-group>, <person-group person-group-type="editor">
<string-name>
<surname>Mirzaa</surname>
<given-names>GM</given-names>
</string-name>
</person-group>
<italic toggle="yes">et&#x000a0;al.</italic> (eds). <source>GeneReviews&#x000ae; [Internet]</source>. <publisher-loc>Seattle, WA</publisher-loc>: <publisher-name>University of Washington</publisher-name>, 2018; <fpage>c1993</fpage>&#x02013;<lpage>c2024</lpage>.</mixed-citation></ref><ref id="deo2398-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="deo2398-cit-0033">
<string-name>
<surname>Kusano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Komazawa</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ito</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Three cases of gastric black dots that appeared after <italic toggle="yes">Helicobacter pylori</italic> eradication</article-title>. <source>Prog Dig Endosc</source>
<year>2017</year>; <volume>90</volume>: <fpage>51</fpage>&#x02013;<lpage>54</lpage>.</mixed-citation></ref></ref-list></back></article>